|
業務類別
|
Biotechnology |
|
業務概覽
|
Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases. |
| 公司地址
| 3027 Townsgate Road, Suite 300, Westlake Village, CA, USA, 91361 |
| 電話號碼
| +1 805 418-5006 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.arcutis.com |
| 員工數量
| 354 |
| Dr. Patrick E. Burnett, M.D.,PhD |
Executive Vice President and Chief Medical Officer |
美元 535.00K |
21/04/2026 |
| Mr. Masaru Matsuda, J.D. |
Executive Vice President, Chief Legal Officer and Corporate Secretary |
美元 495.17K |
21/04/2026 |
| Mr. Todd Franklin Watanabe |
Director, President and Chief Executive Officer |
美元 713.33K |
21/04/2026 |
| Mr. L. Todd Edwards |
Executive Vice President and Chief Commercial Officer |
美元 535.00K |
21/04/2026 |
| Ms. Latha Vairavan |
Principal Accounting Officer, Senior Vice President and Chief Financial Officer |
美元 419.49K |
21/04/2026 |
|
|
| Mr. Keith R. Leonard, Jr |
Chairman of the Board |
21/04/2026 |
| Mr. Patrick J. Heron |
Independent Director |
21/04/2026 |
| Ms. Halley E. Gilbert |
Independent Director |
21/04/2026 |
| Ms. Terrie Curran |
Independent Director |
21/04/2026 |
| Mr. Todd Franklin Watanabe |
Director, President and Chief Executive Officer |
21/04/2026 |
| Dr. Howard G. Welgus, M.D. |
Independent Director |
21/04/2026 |
| Ms. Sue-Jean Lin |
Independent Director |
21/04/2026 |
| Ms. Neha Krishnamohan |
Independent Director |
21/04/2026 |
| Mr. Amit D. Munshi |
Independent Director |
21/04/2026 |
|
|
|
|
